Treatment of recurrent otitis media that developed after total ear canal ablation and lateral bulla osteotomy in dogs: nine cases (1986-1994)

J Am Vet Med Assoc. 1996 Sep 1;209(5):937-42.

Abstract

Objective: To assess clinical findings and long-term outcome of dogs treated for recurrent middle ear infection that developed after total ear canal ablation and lateral bulla osteotomy.

Design: Retrospective case series.

Animals: Of 94 dogs (142 ears) treated by means of total ear canal ablation and lateral bulla osteotomy for end-stage otitis, 9 developed recurrent middle ear infection.

Procedure: Information regarding treatment and outcome were retrieved from the medical records.

Results: Antibiotic treatment was attempted in 8 dogs, but failed to cure recurrent otitis media in 7 of 8 dogs. Seven dogs were treated by means of exploratory surgery, which consisted of ventral bulla osteotomy and tympanic curettage. One dog was cured, 1 developed another infection and was euthanatized, and the 5 remaining dogs developed another middle ear infection after the first exploratory surgery. Infection resolved after retained epithelium was removed from the tympanic cavity during a second exploratory surgery of the bulla in these 5 dogs.

Clinical implications: Antibiotic treatment rarely is effective for resolving recurrent middle ear infection that develops after total ear canal ablation and lateral bulla osteotomy. Ventral bulla osteotomy and curettage can be a successful method of treatment, provided retained epithelium and debris are completely removed from the ear canal and tympanic cavity.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Bacterial Agents / therapeutic use
  • Dog Diseases / etiology*
  • Dog Diseases / therapy*
  • Dogs
  • Ear, Middle / diagnostic imaging
  • Ear, Middle / surgery*
  • Female
  • Male
  • Osteotomy / adverse effects
  • Osteotomy / veterinary*
  • Otitis Media / etiology
  • Otitis Media / therapy
  • Otitis Media / veterinary*
  • Radiography
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents